Maintenance Treatment of Chidamide in Chemotherapy-responded Stage IV or Relapsed/Refractory Extranodal Natural Killer/T-cell Lymphoma, Nasal Type
Latest Information Update: 27 Sep 2023
At a glance
- Drugs Tucidinostat (Primary)
- Indications T-cell lymphoma
- Focus Therapeutic Use
Most Recent Events
- 23 Aug 2018 New trial record